ATE327737T1 - Verfahren zur herstellung von arzneistoffgranulatkörnern, die arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische zubereitungen - Google Patents
Verfahren zur herstellung von arzneistoffgranulatkörnern, die arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische zubereitungenInfo
- Publication number
- ATE327737T1 ATE327737T1 AT02005224T AT02005224T ATE327737T1 AT E327737 T1 ATE327737 T1 AT E327737T1 AT 02005224 T AT02005224 T AT 02005224T AT 02005224 T AT02005224 T AT 02005224T AT E327737 T1 ATE327737 T1 AT E327737T1
- Authority
- AT
- Austria
- Prior art keywords
- granules
- medicinal
- granulates
- pharmaceutical preparations
- preparations containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001064056 | 2001-03-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE327737T1 true ATE327737T1 (de) | 2006-06-15 |
Family
ID=18922942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02005224T ATE327737T1 (de) | 2001-03-07 | 2002-03-07 | Verfahren zur herstellung von arzneistoffgranulatkörnern, die arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische zubereitungen |
Country Status (5)
Country | Link |
---|---|
US (1) | US7192608B2 (de) |
EP (1) | EP1238662B1 (de) |
AT (1) | ATE327737T1 (de) |
DE (1) | DE60211769T2 (de) |
ES (1) | ES2260345T3 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004002486A2 (en) * | 2002-06-27 | 2004-01-08 | Robert Janitzek | Ciprofloxacin hci |
US20060147528A1 (en) * | 2003-02-28 | 2006-07-06 | Deepak Murpani | Extended release, multiple unit dosage forms of phenytoin sodium and processes for their preparation |
US20050025825A1 (en) | 2003-07-31 | 2005-02-03 | Xanodyne Pharmacal, Inc. | Tranexamic acid formulations with reduced adverse effects |
US20090214644A1 (en) * | 2003-07-31 | 2009-08-27 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations with reduced adverse effects |
ITMI20032399A1 (it) * | 2003-12-09 | 2005-06-10 | Zambon Spa | Composizione farmaceutica contenente gabapentina. |
US8022106B2 (en) * | 2004-03-04 | 2011-09-20 | Ferring B.V. | Tranexamic acid formulations |
US7947739B2 (en) | 2004-03-04 | 2011-05-24 | Ferring B.V. | Tranexamic acid formulations |
US20050244495A1 (en) | 2004-03-04 | 2005-11-03 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US20090215898A1 (en) * | 2004-03-04 | 2009-08-27 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
US20050245614A1 (en) * | 2004-03-04 | 2005-11-03 | Xanodyne Pharmaceuticals, Inc. | Tranexamic acid formulations |
AT500144A1 (de) * | 2004-03-05 | 2005-11-15 | Sanochemia Pharmazeutika Ag | Tolperison enthaltende, pharmazeutische zubereitung mit steuerbarer wirkstofffreisetzung zur oralen verabreichung |
CN101198319B (zh) * | 2005-04-26 | 2012-08-01 | 大日本住友制药株式会社 | 含有双胍化合物的颗粒制剂 |
US20080085318A1 (en) * | 2005-07-16 | 2008-04-10 | Cherukuri S R | Coated compositions and methods for preparing same |
EP2050438B1 (de) * | 2006-07-26 | 2016-10-19 | Asahi Kasei Kabushiki Kaisha | Kugelförmiges grobes granulat und herstellungsverfahren dafür |
WO2009011367A1 (ja) * | 2007-07-17 | 2009-01-22 | Asahi Kasei Chemicals Corporation | 水系組成物 |
US20100120776A1 (en) * | 2008-11-12 | 2010-05-13 | Hall Bioscience Corporation | Carbocysteine medical foods |
US20100280117A1 (en) * | 2009-04-30 | 2010-11-04 | Xanodyne Pharmaceuticals, Inc. | Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders |
WO2010138439A1 (en) * | 2009-05-28 | 2010-12-02 | Aptapharma, Inc. | Multiparticulate controlled-release selective serotonin reuptake inhibitor formulations |
EP2338480A1 (de) * | 2009-12-22 | 2011-06-29 | LEK Pharmaceuticals d.d. | Beschichtung von Partikeln mit pharmazeutischen Wirkstoffen mit Carbonatsalz oder Phosphatsalz |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1109425A (en) | 1964-06-16 | 1968-04-10 | Mini Of Technology | Polymeric coating of aspirin |
CA1338596C (en) * | 1988-09-27 | 1996-09-17 | Hiroyoshi Koyama | Granules having core and their production |
ATE128959T1 (de) * | 1989-01-24 | 1995-10-15 | Spi Polyols Inc | Kryoschützende kristalline sorbitolkügelchen. |
FR2663867B1 (fr) | 1990-06-29 | 1994-08-05 | Rhone Poulenc Nutrition Animal | Procede de lissage de granules de principes actifs. |
JP3219787B2 (ja) | 1991-05-28 | 2001-10-15 | フロイント産業株式会社 | 球形粒子の製造方法 |
JPH09175999A (ja) | 1995-12-22 | 1997-07-08 | Freunt Ind Co Ltd | 球形顆粒およびその製造方法 |
JP4090529B2 (ja) | 1996-01-24 | 2008-05-28 | フロイント産業株式会社 | 乳糖の球形粒及びその製造方法 |
JPH09295947A (ja) | 1996-04-30 | 1997-11-18 | Nippon Paper Ind Co Ltd | 微小球形粒及びその製造方法 |
JPH10139659A (ja) | 1996-09-10 | 1998-05-26 | Freunt Ind Co Ltd | 球形粒子群、その製造方法及びそれを用いた球形粒子製剤 |
JP3447042B2 (ja) | 1997-07-23 | 2003-09-16 | フロイント産業株式会社 | 単一物質球形粒の製造方法 |
-
2002
- 2002-03-07 ES ES02005224T patent/ES2260345T3/es not_active Expired - Lifetime
- 2002-03-07 US US10/091,559 patent/US7192608B2/en not_active Expired - Fee Related
- 2002-03-07 DE DE60211769T patent/DE60211769T2/de not_active Expired - Lifetime
- 2002-03-07 AT AT02005224T patent/ATE327737T1/de not_active IP Right Cessation
- 2002-03-07 EP EP02005224A patent/EP1238662B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2260345T3 (es) | 2006-11-01 |
DE60211769T2 (de) | 2007-05-24 |
EP1238662B1 (de) | 2006-05-31 |
US20030039699A1 (en) | 2003-02-27 |
US7192608B2 (en) | 2007-03-20 |
EP1238662A3 (de) | 2003-01-15 |
DE60211769D1 (de) | 2006-07-06 |
EP1238662A2 (de) | 2002-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE327737T1 (de) | Verfahren zur herstellung von arzneistoffgranulatkörnern, die arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische zubereitungen | |
DE69840495D1 (de) | Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben | |
DE122011100049I1 (de) | Stabile pharmazeutische Losungsformulierungen fur unter Druck stehende Inhaliergerate fur die Verabreichung abgemessener Dosen. | |
ATE427109T1 (de) | Flussige pharmazeutische zusammesetzung mit nikotin zur verabreichung in die mundhíhle | |
WO2003002136A3 (en) | Stable formulation of modified glp-1 | |
GEP20063895B (en) | Platinum derivative pharmaceutical formulations | |
ATE355829T1 (de) | Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung | |
ATE198152T1 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
WO2003035051A3 (en) | The use of proton sequestering agents in drug formulations | |
ATE296791T1 (de) | Verfahren zur herstellung von direkt tablettierbarem alpha-mannit | |
ATE326264T1 (de) | Pharmazeutische formulierungen mit kontrollierter wirkstoff-freigabe enthaltend milchsäure-polymer, sowie deren herstellung | |
ATE442852T1 (de) | Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung | |
ATE243193T1 (de) | Benzocycloheptene, verfahren zu ihrer herstellung,pharmazeutische präparate die diese enthalten sowie deren verwendung zur herstellung von arzneimitteln | |
DE60212475D1 (de) | Pharmazeutische Tablette und eine Verfahren zu deren Herstellung | |
HK1068282A1 (en) | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for usein treatment of ulcerative colitis and crohn's di sease | |
DE3884214D1 (de) | Verfahren zur herstellung einer festen form mit beibehaltender freisetzung aus einer funktionellen aktiven komposition und die bei dem verfahren erhaltene dosierungsform. | |
TNSN03106A1 (fr) | Procede pour la production d'une composition pharmaceutique a faible dose ayant une distribution et activite medicamenteuse uniforme | |
ATE230979T1 (de) | Verfahren zur herstellung neuer fenofibrathaltiger arzneiformulierungen, dadurch hergestellte arzneiformulierungen und ihre verwendung | |
ATE262893T1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
IL150528A0 (en) | Ibuprofen containing active agent preparation | |
MXPA05013270A (es) | Forma de administracion transmucosal con irritacion mucosal reducida. reducida. | |
WO2001080619A3 (en) | Pharmaceutical composition containing citalopram | |
ATE245974T1 (de) | Pharmazeutische zusammensetzungen, bestimmt zur oralen verabreichung von phloroglucinol sowie deren herstellung | |
WO2002092565A3 (en) | 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists | |
DE60002089D1 (de) | Niedrig dosierte tabletten, und verfahren zur herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |